Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanjun Su

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Endocrine|July 15, 2024
Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single centerBin Liu, Ying Peng, Yanjun Su, et al.
Jornal De Pediatria|February 9, 2022
Surgical treatment of pediatric and adolescent papillary thyroid cancer: a retrospective study of 54 patients in a single centerYanjun Su, Shaohao Cheng, Chang Diao, et al.
Optics Express|May 27, 2018
Simple method for direct crown base height estimation of individual conifer trees using airborne LiDAR dataLaiping Luo, Qiuping Zhai, Yanjun Su, et al.
Discover Oncology|June 13, 2025
Glutamate activates the MAPK pathway by inhibiting LPAR1 expression and promotes anlotinib resistance in thyroid cancerBin Liu, Ying Peng, Yanjun Su, et al.
Thoracic Cancer|July 7, 2025
Comparative Efficacy of PD-1 Inhibitor-Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II-IIIa NSCLC: A Real-World Retrospective StudyBo Yan, Xiaoxuan Sun, Yan Sheng, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2011
Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietinHui Li, Hua Zhao, Jinpu Yu, et al.
Clinical Epigenetics|March 21, 2025
DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patientsYing Zhou, Jing Zhang, Yang He, et al.
Anti-Cancer Drugs|May 31, 2024
Transcriptome and metabolome sequencing identifies glutamate and LPAR1 as potential factors of anlotinib resistance in thyroid cancerBin Liu, Ying Peng, Yanjun Su, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2018
Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitorsChenguang Li, Hailin Liu, Bin Zhang, et al.
World Journal of Surgical Oncology|March 24, 2023
Single inferior parathyroid autotransplantation during total thyroidectomy with bilateral central lymph node dissection for papillary thyroid carcinoma: a retrospective cohort studyZhizhong Dong, Wen Liu, Ying Peng, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Endocrine|July 15, 2024
Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single centerBin Liu, Ying Peng, Yanjun Su, et al.
Jornal De Pediatria|February 9, 2022
Surgical treatment of pediatric and adolescent papillary thyroid cancer: a retrospective study of 54 patients in a single centerYanjun Su, Shaohao Cheng, Chang Diao, et al.
Optics Express|May 27, 2018
Simple method for direct crown base height estimation of individual conifer trees using airborne LiDAR dataLaiping Luo, Qiuping Zhai, Yanjun Su, et al.
Discover Oncology|June 13, 2025
Glutamate activates the MAPK pathway by inhibiting LPAR1 expression and promotes anlotinib resistance in thyroid cancerBin Liu, Ying Peng, Yanjun Su, et al.
Thoracic Cancer|July 7, 2025
Comparative Efficacy of PD-1 Inhibitor-Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II-IIIa NSCLC: A Real-World Retrospective StudyBo Yan, Xiaoxuan Sun, Yan Sheng, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2011
Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietinHui Li, Hua Zhao, Jinpu Yu, et al.
Clinical Epigenetics|March 21, 2025
DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patientsYing Zhou, Jing Zhang, Yang He, et al.
Anti-Cancer Drugs|May 31, 2024
Transcriptome and metabolome sequencing identifies glutamate and LPAR1 as potential factors of anlotinib resistance in thyroid cancerBin Liu, Ying Peng, Yanjun Su, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2018
Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitorsChenguang Li, Hailin Liu, Bin Zhang, et al.
World Journal of Surgical Oncology|March 24, 2023
Single inferior parathyroid autotransplantation during total thyroidectomy with bilateral central lymph node dissection for papillary thyroid carcinoma: a retrospective cohort studyZhizhong Dong, Wen Liu, Ying Peng, et al.
Pageof 9